Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9 Venous Thromboembolism 8 Venous Thrombosis 7 Pulmonary Embolism 5 Thrombosis 4 Pancreatic Neoplasms 4 Thromboembolism 3 Lymphoma 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Hemorrhage 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thormboembolism 1 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Stroke 1 Stomach Neoplasms 1 Soft Tissue Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1

Interventions

edoxaban 1 Ultrasonography 1 Tranexamic Acid 1 Saline Solution 1 Enoxaparin 1 Dipyrone 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemostatic Disorders × Enoxaparin × Clear all

NCT03570281 2018-06-26

ENCHASE

Samsung Medical Center

Phase 2/3 Unknown

Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡